Search by Drug Name or NDC
NDC 42291-0921-90 Pioglitazone Hydrochloride and Metformin Hydrochloride 850; 15 mg/1; mg/1 Details
Pioglitazone Hydrochloride and Metformin Hydrochloride 850; 15 mg/1; mg/1
Pioglitazone Hydrochloride and Metformin Hydrochloride is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by AvKARE. The primary component is METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE.
MedlinePlus Drug Summary
Metformin is used alone or with other medications, including insulin, to treat type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in the blood). Metformin is in a class of drugs called biguanides. Metformin helps to control the amount of glucose (sugar) in your blood. It decreases the amount of glucose you absorb from your food and the amount of glucose made by your liver. Metformin also increases your body's response to insulin, a natural substance that controls the amount of glucose in the blood. Metformin is not used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). Over time, people who have diabetes and high blood sugar can develop serious or life-threatening complications, including heart disease, stroke, kidney problems, nerve damage, and eye problems. Taking medication(s), making lifestyle changes (e.g., diet, exercise, quitting smoking), and regularly checking your blood sugar may help to manage your diabetes and improve your health. This therapy may also decrease your chances of having a heart attack, stroke, or other diabetes-related complications such as kidney failure, nerve damage (numb, cold legs or feet; decreased sexual ability in men and women), eye problems, including changes or loss of vision, or gum disease. Your doctor and other healthcare providers will talk to you about the best way to manage your diabetes.
Related Packages: 42291-0921-90Last Updated: 04/07/2024
MedLinePlus Full Drug Details: Metformin
Pioglitazone is used with a diet and exercise program and sometimes with other medications, to treat type 2 diabetes (condition in which the body does not use insulin normally and therefore cannot control the amount of sugar in the blood). Pioglitazone is in a class of medications called thiazolidinediones. It works by increasing the body's sensitivity to insulin, a natural substance that helps control blood sugar levels. Pioglitazone is not used to treat type 1 diabetes (condition in which the body does not produce insulin and, therefore, cannot control the amount of sugar in the blood) or diabetic ketoacidosis (a serious condition that may develop if high blood sugar is not treated). Over time, people who have diabetes and high blood sugar can develop serious or life-threatening complications, including heart disease, stroke, kidney problems, nerve damage, and eye problems.Taking medication(s), making lifestyle changes (e.g., diet, exercise, quitting smoking), and regularly checking your blood sugar may help to manage your diabetes and improve your health. This therapy may also decrease your chances of having a heart attack, stroke, or other diabetes-related complications such as kidney failure, nerve damage (numb, cold legs or feet; decreased sexual ability in men and women), eye problems, including changes or loss of vision, or gum disease. Your doctor and other healthcare providers will talk to you about the best way to manage your diabetes.
Related Packages: 42291-0921-90Last Updated: 04/07/2024
MedLinePlus Full Drug Details: Pioglitazone
Product Information
NDC | 42291-0921 |
---|---|
Product ID | 42291-921_f6cd8e3d-8b02-18e5-e053-6294a90a075f |
Associated GPIs | |
GCN Sequence Number | 059686 |
GCN Sequence Number Description | pioglitazone HCl/metformin HCl TABLET 15MG-850MG ORAL |
HIC3 | C4T |
HIC3 Description | ANTIHYPERGLYCEMIC, THIAZOLIDINEDIONE AND BIGUANIDE |
GCN | 25445 |
HICL Sequence Number | 033202 |
HICL Sequence Number Description | PIOGLITAZONE HCL/METFORMIN HCL |
Brand/Generic | Generic |
Proprietary Name | Pioglitazone Hydrochloride and Metformin Hydrochloride |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Pioglitazone Hydrochloride and Metformin Hydrochloride |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | TABLET, FILM COATED |
Route | ORAL |
Active Ingredient Strength | 850; 15 |
Active Ingredient Units | mg/1; mg/1 |
Substance Name | METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE |
Labeler Name | AvKARE |
Pharmaceutical Class | Biguanide [EPC], Biguanides [CS], PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [E |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA200823 |
Listing Certified Through | 2024-12-31 |
Package
NDC 42291-0921-90 (42291092190)
NDC Package Code | 42291-921-90 |
---|---|
Billing NDC | 42291092190 |
Package | 90 TABLET, FILM COATED in 1 BOTTLE (42291-921-90) |
Marketing Start Date | 2023-03-13 |
NDC Exclude Flag | N |
Pricing Information | N/A |